ROIV - Roivant Sciences Ltd.
29.72
0.200 0.673%
Share volume: 9,137,320
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$29.52
0.20
0.01%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | Q3 2025 | |
| Report Date | 08-14-2023 | 11-12-2024 | 02-10-2025 | 05-29-2025 | 11-10-2025 | 02-06-2026 | |
| Assets | |||||||
| Total Assets | 2.137 B | 6.206 B | 5.792 B | 5.437 B | 5.063 B | 5.225 B | |
| Current Assets | 1.561 B | 5.801 B | 5.364 B | 5.000 B | 4.512 B | 4.660 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 127.065 M | 94.226 M | 217.460 M | 113.173 M | 125.811 M | 129.912 M | |
| Short Term Investments | 127.065 M | 3.428 B | 3.156 B | 2.171 B | 3.149 B | 3.052 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.434 B | 1.959 B | 1.991 B | 2.715 B | 1.237 B | 1.478 B | |
| Total Non-current Assets | 575.488 M | 311.354 M | 290.040 M | 302.939 M | 412.315 M | 433.907 M | |
| Property Plant Equipment | 36.270 M | 13.674 M | 13.563 M | 12.056 M | 25.667 M | 13.447 M | |
| Other Assets | 97.938 M | 391.235 M | 414.814 M | 424.820 M | 525.285 M | 552.031 M | |
| Intangible Assets | 145.037 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 2.137 B | 6.206 B | 5.792 B | 5.437 B | 5.063 B | 5.225 B | |
| Total liabilities | 1.226 B | 625.986 M | 256.375 M | 249.742 M | 257.140 M | 251.144 M | |
| Total current liabilities | 245.004 M | 556.249 M | 141.484 M | 149.411 M | 133.857 M | 151.964 M | |
| Accounts Payable | 50.035 M | 25.127 M | 23.712 M | 23.691 M | 15.064 M | 13.294 M | |
| Other liabilities | 120.622 M | 69.737 M | 114.891 M | 100.331 M | 123.283 M | 99.180 M | |
| Current long term debt | 55.754 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 436.881 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 120.622 M | 69.737 M | 114.891 M | 100.331 M | 123.283 M | 99.180 M | |
| Minority interest | 423.409 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 910.730 M | 5.153 B | 5.189 B | 4.688 B | 4.362 B | 4.269 B | |
| Common stock | 759.274 M | 4.775 B | 4.721 B | 4.562 B | 4.772 B | 4.944 B | |
| Retained earnings | -4.065 B | 395.580 M | 460.398 M | 116.060 M | -429.107 M | -694.998 M |